Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,736,767
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
13,907,881
-
Shares change
-
+1,467,042
-
Total reported value, excl. options
-
$126,979,303
-
Value change
-
+$14,714,242
-
Put/Call ratio
-
184%
-
Number of buys
-
32
-
Number of sells
-
-15
-
Price
-
$9.13
Significant Holders of GeneDx Holdings Corp. - Common Stock (WGS) as of Q1 2024
68 filings reported holding WGS - GeneDx Holdings Corp. - Common Stock as of Q1 2024.
GeneDx Holdings Corp. - Common Stock (WGS) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,907,881 shares
of 28,736,767 outstanding shares and own 48.4% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (3,136,411 shares), Corvex Management LP (2,473,781 shares), ORACLE INVESTMENT MANAGEMENT INC (1,126,607 shares), GOLDMAN SACHS GROUP INC (1,125,115 shares), Blackstone Inc. (835,062 shares), MORGAN STANLEY (793,481 shares), Soleus Capital Management, L.P. (783,376 shares), VANGUARD GROUP INC (707,612 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (643,110 shares), and GAGNON SECURITIES LLC (556,305 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.